Making Sense of Cancer Evolution with Next Generation Sequencing
Anthony Papenfuss, Head, Bioinformatics and Cancer Genomics Laboratory, Peter MacCallum Cancer Centre
Cancer is a genetic disease in
populations of cells that is underpinned by evolution and selection.
Tumorigenesis, disease progression, metastasis, and the emergence of
heterogeneity and therapy resistance are all evolutionary processes. Dramatic
decreases in the costs of sequencing genomes have enabled new deep insights
into these processes. In this talk, I will discuss some of our own experiences
investigating tumour evolution focused on two examples. In the first and conceptually simpler
example, we sequenced primary melanomas and multiple metastases obtained from a
rapid autopsies. We have used these data to infer the evolution of melanoma
metastases. I will briefly describe what we have learnt, and some of the
roadblocks to understanding and how we are trying to overcome these.
In the second example, we sequenced DNA
from flow isolated cancer-associated neo-chromosome
|
|